- Home
- TNGX vs MERC Comparison
TNGX vs MERC Comparison
Compare TNGX & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- MERC
- Stock Information
- Founded
- TNGX 2014
- MERC 1968
- Country
- TNGX United States
- MERC Canada
- Employees
- TNGX N/A
- MERC N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- MERC Paper
- Sector
- TNGX Health Care
- MERC Basic Materials
- Exchange
- TNGX Nasdaq
- MERC Nasdaq
- Market Cap
- TNGX 413.6M
- MERC 428.0M
- IPO Year
- TNGX N/A
- MERC 1987
- Fundamental
- Price
- TNGX $3.04
- MERC $6.82
- Analyst Decision
- TNGX Strong Buy
- MERC Hold
- Analyst Count
- TNGX 8
- MERC 2
- Target Price
- TNGX $13.14
- MERC $7.75
- AVG Volume (30 Days)
- TNGX 1.5M
- MERC 365.8K
- Earning Date
- TNGX 11-06-2024
- MERC 02-13-2025
- Dividend Yield
- TNGX N/A
- MERC 4.40%
- EPS Growth
- TNGX N/A
- MERC N/A
- EPS
- TNGX N/A
- MERC N/A
- Revenue
- TNGX $43,383,000.00
- MERC $2,025,449,000.00
- Revenue This Year
- TNGX $27.73
- MERC $4.77
- Revenue Next Year
- TNGX N/A
- MERC $1.72
- P/E Ratio
- TNGX N/A
- MERC N/A
- Revenue Growth
- TNGX 15.67
- MERC N/A
- 52 Week Low
- TNGX $2.70
- MERC $5.33
- 52 Week High
- TNGX $13.01
- MERC $11.20
- Technical
- Relative Strength Index (RSI)
- TNGX 39.30
- MERC 59.27
- Support Level
- TNGX $2.72
- MERC $5.97
- Resistance Level
- TNGX $3.29
- MERC $6.54
- Average True Range (ATR)
- TNGX 0.30
- MERC 0.30
- MACD
- TNGX 0.07
- MERC 0.03
- Stochastic Oscillator
- TNGX 32.08
- MERC 93.41
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The solid wood segment consists of the manufacture, sale, and distribution of lumber, manufactured products wood pallets, electricity, biofuels, and wood residuals from sawmills and other facilities located in Germany and the United States. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.